DIVERSA

At DIVERSA we specialize in pharmaceutical technology and #drugdelivery solutions using our lipid nanoemulsions. Today we are starting our participation #bioeuropespring and look forward to connecting with many prospective partners. Let's start the therapeutic revolution. Thanks to Scienseed for this beautiful animation video.

Revolutionizing Drug Development with Advanced Technologies 🚀 Discover how AI, nanotechnology, organoids, and organ-on-a-chip models are revolutionizing drug delivery and enhancing our understanding of biological mechanisms. 💻 Read our latest article to explore the transformative impact of these technologies in drug development. 👉 https://lnkd.in/dxW79nSk 💡 At DIVERSA, we remain dedicated to pushing the boundaries of drug discovery to develop therapies that truly improve patient outcomes 🔬. #DrugDiscovery #DrugDelivery #AI #Nanotechnology #Innovation #Biotechnology #Research

📢 Latest updates from DIVERSA! – Save the dates for these key events 🗓️ In the coming months, DIVERSA will be attending several important events in the pharmaceutical and biotechnology industry. Don’t miss out! Here are the dates and locations where you can find us: • CPHI: October 8th-10th, Milan. • Festival of Biologics: October 15th-17th, Basel. • BIO-Europe: November 4th-5th, Stockholm. • Cell & Gene Therapy International Europe: December 1st-4th, Dublin. Our team of experts will be in these events: 👩⚕️ Maria de la Fuente Freire – CEO/CSO & Co-Founder 👩💼 Abi J Vázquez – COO & Co-Founder 👨💼 Guillermo Calvo Navarrete – Business Developer Manager 👩🔬 Laura Taina-González – Formulation Specialist We will be next week at CPHI in Milan 🎯 Come meet us and discover how DIVERSA is driving pharmaceutical innovation! 🙌 💡 Remember that we announce these and other updates in our newsletter. If you haven’t subscribed yet, do it now to stay informed! 👉 https://shorturl.at/ZuQRV We would love to see you at one of these events! #DIVERSA #CPHI #Bioeurope2024 #FestivalofBiologics #Cell&GeneTherapy #Networking #PharmaceuticalInnovation #ScienceAndTechnology

🚨 Last Day to Enjoy Our 20% Launch Discount on mRNA Products 🚨 Don't miss out! Take advantage of our 20% launch discount on mRNA delivery nanoparticle formulations. Explore our full-size nanoparticle formulations, optimized for 20 µg of mRNA. What we offer: - User-Friendly & Efficient Method - Quick & Effective Delivery - Biocompatibility - Customization & Traceability tailored to your needs. 🌟 Exclusive offer: Special pricing on samples for 5 µg of mRNA of our mRNA Delivery Nanoparticles. Contact us to learn more at [email protected]!   🎁 BONUS: Free technical support from our team of experts to help you optimize your research. 📬 Subscribe to our newsletter to know more details about this offer and to stay updated on the latest offers, innovations, and research insights in nanomedicine: https://shorturl.at/ZuQRV #Nanomedicine #mRNAtechnology #ScientificResearch #Innovation #Science #Nanoparticles

🌍✨ World Cancer Research Day - September 24 ✨🌍 World Cancer Research Day is crucial for raising awareness about the importance of research in developing effective treatments and improving outcomes for cancer patients worldwide. DIVERSA is strongly committed to contribute to cancer research through the application of nanotechnology for the development of innovative therapeutics to overcome current unmet clinical needs. As a spin-off from Servizo Galego de Saúde and Health Research Institute of Santiago de Compostela, and incubated in a hospital, we are acutely aware of the pressing need for advancements that can improve patient care. At this stage, we are dedicated to the development of new therapies to improve the efficacy and safety of cancer treatments. As we observe World Cancer Research Day, we reinforce our dedication to innovation and the goal of bringing new therapies to patients more efficiently. Together, we can make a difference in the fight against cancer! 💪💙 #WorldCancerResearchDay #CancerResearch #Nanotechnology #Innovation #Immunotherapy #DIVERSA

🚀Introducing Our New ICEX VIVES Fellow!   We are excited to welcome Jurgi Perez, our new ICEX VIVES fellow, who will be collaborating with PROGEN in Heidelberg to support the commercial efforts of DIVERSA's advanced lipid nanoparticles for drug delivery and gene therapy 💊🧬 After an intensive two-week training with our team, Jurgi is ready to work alongside our partners in Germany, applying the valuable insights gained from DIVERSA’s innovative technology. As highlighted by Jurgi, here are the key strengths of DIVERSA’s technology: 🔹User-friendly formulation: "Simple calculations and pipetting-based formulation. Ready to go!" 🔹Biocompatibility: "Transfected cells thrive with DIVERSA!" 🔹Modularity and Flexibility: "Comprehensively and effortlessly customizable." 🔹Scalability: "A huge gain vs viral vectors! Forget costly and tedious purification processes and cell culture." With Jurgi now in Heidelberg, we look forward to strengthening our collaboration with PROGEN and expanding the reach of our lipid nanoparticle solutions. #InnovationInBiotech #DrugDelivery #GeneTherapy #LipidNanoparticles #Biotechnology #ICEXVIVES #Nanomedicine #NextGenTherapies

Innovative Nanomedicine Strategies: Overcoming Liver Tropism in Advanced Gene Therapies   💻 A new blog entry features a recent article that explores innovative strategies to overcome nanoparticle accumulation in the liver, and provides an overview on the latest advances in the field. 💡 Advancements in non-viral vectors are opening new frontiers in drug delivery and have the potential to transform the treatment of complex diseases    #Nanomedicine #DrugDelivery #Innovation #Biotechnology #Health #Science #Research

🚀 At DIVERSA, we are committed to continuos learning! We believe that the key to success lies in the continuous development of our team. That is why we encourage the constant training of our employees, ensuring their professional career is versatile and aligned with the latest trends in the biotechnology sector 📚 We are proud to have a team that is always ready to learn, evolve and adapt to new market challenges: Maria de la Fuente Freire, our CEO/CSO, together with Abi J Vázquez, our COO, and Iolanda Otero Barroso, our Administrative and Resource Manager, have successfully completed the basic course in labor equality organized by the Xunta de Galicia, which focuses on implementing equality policies, negotiating equality plans, and developing protocols against harassment. Sara Vicente, our Project and Innovation Manager, has participated in an informational session on the European call #EU4HEALTH, focusing on innovation opportunities in the healthcare sector and various European funding possibilities. Irene Morín Jiménez, our Lab Technician, completed the Shipping with Dry Ice course organized by Eduwhere, to acquire the necessary skills for the safe and efficient handling of dry ice shipments. Together with Irene, Laura Cañada García, our Research Scientist, they expanded their training through the Malvern Course provided by IESMAT - Instrumentación Especifica de los Materiales S.A., specializing in particle characterization using advanced analytical techniques. 🙌 When our team grows, we all grow together 💪 #ProfessionalDevelopment #ContinuousLearning #DIVERSA #Growth #DIVERSATeam #Talent

🌟 DIVERSA Delivery Nanoparticles at SEBBM 2024 🌟 Our innovative Delivery Nanoparticles will be featured at the 46th Congress of the Sociedad Española de Bioquímica y Biología Molecular (SEBBM) in A Coruña, from September 3rd to 6th, 2024! These nanoparticles are designed for the efficient delivery of all types of molecules, offering advanced solutions for research and development in nanomedicine. Whether for drugs, proteins, peptides, or nucleic acids, DIVERSA Delivery Nanoparticles enhance delivery and transfection. Make sure to visit the LABCLINICS, S.A booth during the congress to explore this cutting-edge technology and take advantage of incredible offers on our products. Don’t miss out on this opportunity! ✨ #DIVERSA #DeliveryNanoparticles #SEBBM2024 #Nanomedicine #Innovation #Biochemistry #Science #LabClinics

Meet five new start-ups joining us in a month's time! 🚀 We are delighted to welcome: Bio-Sourcing, DIVERSA Technologies, fungtional.bio, kyron.bio, Z7 Biotech Ltd! These biologics startups explores areas in #nanotechnology, specialising in #mRNA therapeutics for immuno-oncology and #geneediting technologies targeting #rarediseases, digital-first #insilico simulation engine, and #glycan engineering technology. Don't miss out on their exhibition and showcase 👉 https://lnkd.in/eVfs_-cH #festofbiologics #festivalofbiologics